{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Sangamo Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"SGMO"},"Address":{"label":"Address","value":"7000 MARINA BOULEVARD, BRISBANE, California, 94005, United States"},"Phone":{"label":"Phone","value":"+1 510 970-6000"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies."},"CompanyUrl":{"label":"Company Url","value":"https://www.sangamo.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexander D. Macrae","title":"President, Chief Executive Officer & Director"},{"name":"Gregory Davis","title":"Head-Technology"},{"name":"Phillip Ramsey","title":"Head-Technical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}